Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Turnstone Biologics

Turnstone Biologics
2015 FOUNDED
PRIVATE STATUS
61-70 EMPLOYEES
Corporate LATEST DEAL TYPE
$120M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of viral immunotherapies designed to improve survival for patients with cancer. The company's immunotherapies combine a bio-selected and engineered oncolytic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate tumor environment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 12 York Street
  • 3rd Floor
  • Ottawa, Ontario K1S 3V5
  • Canada

+1 (613) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Turnstone Biologics’s full profile, request a free trial.

Turnstone Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Corporate 19-Dec-2019 $120M 00000 Completed Pre-Clinical Trials
4. Later Stage VC (Series C) 04-Jan-2019 0000 000.00 Completed Pre-Clinical Trials
3. Early Stage VC (Series B) 02-Nov-2016 000.00 000.00 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 28-Oct-2015 $11.3M $11.3M Completed Pre-Clinical Trials
1. Angel (individual) 04-May-2015 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Turnstone Biologics Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAtrix Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
00000000 Corporate Backed or Acquired Seal Beach, CA 000 00.000 000000&0
000000 Angel-Backed Lyon, France 00 00.000 0000000000 00.000
0000000 Formerly VC-backed London, United Kingdom 000 00000 000000 - 000 00000
0000000 Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

Turnstone Biologics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Takeda Pharmaceutical Company Corporation Minority 000 0000 000000 0
Brace Pharma Capital Corporate Venture Capital Minority 000 0000 000000 0
Eight Roads Venture Capital Minority 000 0000 000000 0
Sectoral Asset Management Asset Manager Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Turnstone Biologics Executive Team (11)

Name Title Board
Seat
Contact
Info
Sammy Farah Ph.D Chief Executive Officer, President & Board Member
Jane Henderson Chief Financial Officer
David Stojdl Ph.D Scientific Co-Founder & Senior Vice President, Research
Brian Lichty Ph.D Scientific Founder
Steve Bernstein MD Senior Vice President, Clinical Research & Development

1 Former Executive

You’re viewing 5 of 11 executives. Get the full list »

Turnstone Biologics Board Members (9)

Name Representing Role Since Contact
Info
Ben Auspitz F-Prime Capital Partners Board Member 000 0000
Bradley Bolzon Ph.D Versant Venture Management Board Member 000 0000
Jeff Courtney Fight Against Cancer Innovation Trust Board Member 000 0000
Jerel Davis Ph.D Versant Venture Management Board Member 000 0000
Patrick Machado JD Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »